Whether you’re a senior in high school or a senior-living resident, you’ve likely heard of Viagra (sildenafil) — the original ...

While a stuffy nose is a common side effect of oral ED medications, switching from Cialis to shorter-lasting options like ...

Christmas week in 2024 sure feels a lot like Christmas week of 2023 for the Jacksonville Jaguars. This time last year, the Jaguars were limping into the final weeks of the season with an injury ...

Operatives of the National Drug Law Enforcement Agency (NDLEA) have busted drug smuggling operations and recovered over one million pills of opioids in various locations across the country. According ...

The tech entrepreneur follows a strict protocol, which includes taking over 50 pills daily, undergoing plasma transfusions, fat transfers, and even exploring gene therapy. The trailer offers a ...

US company Viatris has created a new version of Viagra, which is also known as sildenafil, but instead of being a tablet, the new form is a wafer-like film ... the little blue pill has become ...

over an obstacle. A large swarm of 1,000 microrobots with high packing density formed a raft that floated on water and wrapped itself around a pill that weighed 2,000 times more than each ...

These are all the shows like Black Doves that should satisfy your craving for thrilling narratives over Christmas and the New Year. If you didn’t obsess over The Diplomat last year, now is your ...

Merck announced on Wednesday that it has inked a global licensing partnership with Chinese biotech Hansoh Pharma to advance a GLP-1 receptor agonist pill, jumping into an already ... Hansoh will ...

Many women are adamant that taking the Pill makes them gain weight – yet researchers have repeatedly not been able to find a link. But a new study suggests that some women do put on weight while ...

About half of men over 40 suffer erectile dysfunction in the UK and last year there was a record 4.57million prescriptions for Viagra ... contaminants like heavy metals or other drugs that could ...

Over the same period ... a trend the company attributed in part to the GLP-1 drugs. The medications are "bringing people into primary care like never before," ResMed CEO Michael Farrell said ...